A carregar...
Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment
Abstract Purpose The phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) pathway controls insulin sensitivity and glucose metabolism. Hyperglycemia is one of the most common on‐target adverse effects (AEs) of PI3K/AKT inhibitors. As several PI3K and AKT inhibitors are approved by the United Stat...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Wiley
2022-04-01
|
Colecção: | Cancer Medicine |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1002/cam4.4579 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...